Genoa Science Festival · Oct 26 – Nov 5 2023 | Anno XXI

Rulex is thrilled to participate in the 2023 edition of the Science Festival in Genoa, Italy.
The twenty-first edition of the Genoa Science Festival, themed “Footprints”, will be held from October 26th to November 5th, at some of the city’s most charming and historically significant venues.

Rulex will be located at the Palazzo della Borsa, hosting a workshop titled “Tracking down the Fraudster” (“Sulle orme del truffatore”). During this workshop, participants will have the opportunity to analyze the data provided by an insurance company, learning how to tell apart genuine claims from suspicious incidents and downright frauds. Their deductions will then be compared to those generated by the “Logic Learning Machine” (LLM); an explainable AI algorithm created by Rulex’s visionary founder. This algorithm lies at the core of an award-winning fraud detection solution, trusted by some of Italy’s major insurance companies and financial institutions. Unlike its competitors, the LLM generates crystal-clear rules that can be easily integrated with business experts’ knowledge and applied to new data to classify results. Its transparency makes it particularly suitable for ethically sensitive sectors, while also ensuring compliance with privacy regulations.

Please note that, while English language support is available, the workshop has primarily been designed for an Italian-speaking audience.

About Rulex

Rulex helps people and organizations to harness their data and make smart decisions, through a user-friendly end-to-end data management platform. With advanced optimization, innovative explainable AI, and a wide range of machine learning tools, Rulex delivers high-quality, trusted, and production-ready solutions for various industries, including supply chain, financial services, manufacturing, and marketing.

For additional information:
Claire Thomas Gaggiotti
Head of Communications
info@rulex.ai

Discover Rulex Platform and witness the power of true data agility.

Start a free 30-day trial and unlock the full potential of your data.

Panorama – 2 agosto 2023 |Anno LXI – N° 32

The Genoese company has gained global recognition through the development of highly innovative technology.
The world of data and artificial intelligence can sometimes seem elitist, reserved for those who have spent their lives studying the technology that has enabled the computer revolution. However, there are innovative companies that have set out to make this world accessible to a broader audience, easily and efficiently usable not only by specialized professionals but also by everyday people. One such company is Rulex, a young and dynamic enterprise that produces innovative data management software.

Rulex helps businesses leverage and improve their data, using it as a foundation for making strategic decisions or optimizing business processes. The range of potential solutions is almost limitless, including transport optimization in logistics, anti-fraud systems in banks, biomedical research, predictive maintenance for manufacturing industries, dynamic pricing strategies, and much more.

In 2014, Rulex launched the first version of its software, enabling users to independently manage business data without programming skills. To better meet user needs, Rulex Platform has been launched this year—a comprehensive product for building solutions that deliver immediate and actionable results in just a few minutes. The platform features an interactive web-interface based on the latest innovative technology and includes two components: Rulex Factory, where solutions are built from data, and Rulex Studio, which visually presents results through interactive dashboards. These interconnected components allow users, generally called Citizen Developers, to gather, process, and present their data in a single platform, without having to switch environments or need programming skills. Intuitiveness, speed, and a high level of interactivity—everything you need to truly democratize the data analysis process.

“Rulex Platform has the ability to capture data wherever it is,” explains Rulex’s CEO, “which could be in simple Excel files on laptops, tables in remote databases, web documents, or email attachments. We also offer a wide range of algorithms, including artificial intelligence techniques, which are able to provide human-readable explanations for each analysis performed. The uniqueness of these techniques lies not just in their predictive capabilities but in their ability to explain these predictions through extremely clear rules. Thanks to this, our clients can make strategic decisions that can actually influence the future, rather than passively accepting negative forecasts. Our technology is young and has enormous room for growth, very much like our team.”

Indeed, Rulex has managed to make a global impact despite (or thanks to?) the young age of its staff, with an average age of 30, and has gained the trust of giants such as Kraft-Heinz, Reckitt, UnipolSai, Banco BPM, Monte dei Paschi di Siena, British American Tobacco, Volvo, and Enel. “Certain technologies require young minds and particular attention to everything that is going on in the IT sector,” says Muselli. “That’s why we invest 60 percent of our profits in research and development and establish crucial partnerships with American universities like Tuskegee and New York University, as well as Italian universities such as the University of Genoa and Milano-Bicocca. We reach out to new graduates and those willing to learn and navigate a new world of programming languages and algorithms which we ourselves create from scratch. We can proudly say that we operate at the highest levels of expertise to put technology at the service of those without technical skills—a mission that pushes us further into the future.”

The piece is a translation of the original article in Italian curated by Prima Pagina Italia.

Discover Rulex Platform and witness the power of true data agility.

Start a free 30-day trial and unlock the full potential of your data.

Genoa, June 1, 2023 – OMP and Rulex announce the extension of their partnership to further enhance data quality in supply chain planning by providing tighter integration between Rulex Platform and OMP’s Unison Planning™.

Streamlined data quality management

The success of supply chain planning decisions depends on the precision of the underlying data, which may encompass details on products, inventory, resources, capacity, suppliers, or orders. With the continuously growing volume and complexity of such data and the expanding network of sources, innovative approaches are needed to harmonize and validate the constant flow of data.

OMP and Rulex are already collaborating on driving innovation in the data value chain to improve decision-making in supply chain planning. Today, they expand their partnership through the joint creation of an OMP-Rulex connector. This connector will leverage Rulex Platform’s data consolidation and validation capabilities to streamline the deployment of OMP’s Unison Planning™ Solution.

Intensified collaboration

The collaboration focuses on improving the quality of master and operational data through cleansing and validation functionalities, enabling streamlined integration into the OMP digital twin. OMP customers will be able to accelerate the implementation of Unison Planning™ and enhance their ability to manage a varying data landscape while using the supply chain planning solution.

Both companies will increase their capacity to implement relevant data validation logic into Rulex Platform. In addition to developing a dedicated platform extension, Rulex and OMP will jointly market this solution and are initiating a pilot program to allow key customers to participate in the design. Rulex will also participate in the 2023 OMP Conference (Barcelona, September 27 & 28).

The expansion of the commercial and innovation collaboration confirms OMP’s commitment to helping customers address the data management challenge that results in longer implementation tracks, reduced efficacy of supply chain planning processes, and less-than-optimal business value creation. Jan Snoeckx, OMP Innovation Lead, says, “This collaboration leverages OMP’s ecosystem and fits perfectly in the product strategy to offer our joint customers the best possible solution, powered by our composable and open supply chain planning platform.”

Claire Thomas Gaggiotti, Rulex Head of Sales and Marketing, adds, “The further integration of our platforms comes as a natural result of the growing demand from our joint customers, who are seeking enhanced data quality and quicker value creation. By streamlining the integration process, we’re enabling our clients to capitalize on the benefits of our combined solutions more effectively and make more informed, data-driven decisions in their supply chain planning.”

The partnership extension demonstrates the deep commitment shared by OMP and Rulex to improve data quality in supply chain planning and provide customers with the best possible solutions for optimal decision-making.

About Rulex

Rulex is a leading technology company delivering a no-code, end-to-end data management system, called Rulex Platform, which orchestrates all the steps in the data value chain (from data collection to pre-processing and advanced analytics), providing businesses with high-quality, trusted, and ready-to-use data.

Rulex Platform enables business users, from any industry or organization, to autonomously interact with their own data, building solutions adapted to their specific business needs, to take better decisions, improve efficiency, and/or automate business processes.

About OMP

OMP helps companies facing complex planning challenges to excel, grow and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries – spanning consumer goods, life sciences, chemicals, metals, paper and packaging – benefit from using OMP’s unique Unison Planning™.

 

Contact information

OMP	Rulex
Jan Snoeckx OMP Innovation Lead Phone: +32 475 75 04 82 Email: jsnoeckx@omp.com	Claire Thomas Gaggiotti Rulex Head of Sales and Marketing Phone: +39 333 812 8032 Email: claire.thomasgaggiotti@rulex.ai
Paul Delbar OMP Technology Alliance Lead Phone: +32 471 046 662 Email: pdelbar@omp.com

Milano, 1 March 2023 – The University of Milano-Bicocca and the tech company Rulex have signed an agreement to strengthen their current research collaboration, extending it to new projects and fields of study, and to open a training partnership.

At the heart of the agreement is the application of Rulex Platform, an advanced data management tool, to the medical field, in particular hepatology. The project contacts are Damiano Verda, Head of Data Science at Rulex, and Alessio Gerussi, lecturer in gastroenterology at Milano-Bicocca University.

The collaboration dates back to 2019 and has already delivered exceptional results in the medical field. The most recent results were published in Liver International, in March 2022, in the article The application of machine learning in primary biliary cholangitis, which was also chosen to be the cover of the issue. This was followed by two publications: Artificial intelligence for precision medicine in autoimmune liver disease in Frontiers in Immunology (November 2022) and LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis in the Journal of Personalized Medicine (September 2022), which involved the collaboration of IRCCS (Humanitas Clinical and Research Center).

Damiano Verda comments on the research: “The work carried out with Milano-Bicocca University until now, which will draw new impetus from the recent signing of the agreement, has allowed us to test the potential of Rulex Platform and of the Logic Learning Machine model in the important and delicate field of medicine. Naturally, we are happy to have obtained important initial results, but we are even more determined to imagine new paths of growth and development, strengthened by what we have learned and will continue to learn”.

Other points of the agreement include extending current combined research to new fields of study, the launch of Industrial PhD programs, and participation in the Rulex University Program. The program offers university students free online training to build data analysis skills, which are increasingly a fundamental requirement in many lines of work, including medical research.

Genoa, 8 June 2022 – UniGe (University of Genoa) and Rulex, the digital transformation and artificial intelligence specialists, have signed an agreement to strengthen their training and research partnership, aiming to support students as they move from university into the world of employment.

At the core of the agreement is UniGe’s involvement in the Rulex University Program, which offers university students online study pathways and professional certifications in subjects ranging from data collection and analysis to using AI algorithms to predict future scenarios and optimise industrial processes.

“The wireless telecoms networks of the future will enable much faster data transfer speeds than we see today, a greater number of connected devices and much higher volumes of traffic, with very few delays. This will enable us to create applications that were unthinkable until very recently. The ability to manage and process Big Data using artificial intelligence-based models, algorithms and software will be strategic both in developing new services and guaranteeing security”, explains Professor Mario Marchese, Telecommunications lecturer at UniGe and Deputy Rector for the PhD program.

The online courses are an option for the Master’s Degree in Computer Science supervised by Professor Alessandro Verri, and are designed to be accessible to all UniGe students.

“Rulex Academy gives students from all faculties, scientific or not, the skills they need to analyze and process data, an increasingly fundamental requirement for the world of work”, says Claire Thomas Gaggiotti, Head of Rulex Academy.

As well as UniGe, other international universities have chosen to include Rulex Academy’s educational programs within their curricula. New York University (NYU) runs the Rulex Data-Driven Marketing course as part of its Master in Integrated Marketing, in association with Professor Federico Salvitti; Tuskegee University has been readying students for the world of work with Rulex’s professional courses for over 4 years, under the leadership of Professor Jack Crumbly.

The new agreement confirms the long-term research partnership between UniGe and Rulex, alongside prestigious global partners. “Genoa is a world-leader in artificial intelligence; the synergy between the university and the company will be vital in developing a virtuous circle in both Italy and Europe”, explains Enrico Ferrari, Head of R&D Projects.

A global-minded company with its heart in Genoa, Rulex has always worked with the University of Genoa, running internships and experimental theses that often lead to lasting working relationships and permanent contracts. “Doing work experience with us helps students hone their practical skills, narrowing the gap between university and employment, and making it easier for recent graduates to embark on their careers”, comments the Head of HR, Finance and Administration Italy.

University of Genoa contact:
Eliana Ruffoni
relazioniesterne@unige.it
+39 392 023 6359

Rulex contact:
Claire Thomas Gaggiotti
claire.thomasgaggiotti@rulex.ai
+39 333 812 8032

For further information on:

• Training: Sivia Parma silvia.parma@rulex.ai
• Careers guidance and recruiting: HR hr@rulex.ai
• Research and development: Enrico Ferrari enrico.ferrari@rulex.ai

ATLANTA, GA — June 7, 2022 — OMP and Rulex join forces to bring innovative data value stream technologies into supply chain management.

Both companies’ emphasis on innovation and customer value, OMP’s Unison Planning^TM Solution combined with the unique Rulex approach to data quality and decision automation, will allow customers to implement a more robust and automated data-driven supply chain planning process.

Building trust in the decision-making process

In today’s complex business environment, it is increasingly critical to make the right supply chain planning decisions. Planners need to provide reliable, accurate, and trusted inputs to supply chain processes, making sense of the huge volumes of master and operational data from a wide variety of sources. Data quality is often low due to multiple different formats and, inevitably, human error creeps in.

OMP Unison Planning™ optimizes an organization’s supply chain — from sales and operations to logistics and procurement — ensuring the company is aligned on strategic goals, and is the trusted solution adopted by Fortune 500 companies such as Procter & Gamble, Johnson & Johnson, and BASF.

“Data quality is a primary concern in every transformation initiative,” says Jan Snoeckx, OMP Innovation Lead. “Our customers are looking for innovative ways to prepare the necessary data in an automated way, by providing business users with a solution to quickly integrate new insights into master and transactional data. Above all, that process needs to be transparent and explainable, so that planning processes and decision-making run smoother with better trust in the underlying data.”

Rulex Platform integrates data-driven knowledge with human expertise, automating repetitive tasks and decision-making. But, to make a real difference, experts must be able to trust technical innovation. This is precisely why Rulex Platform is 100% no-code, and its eXplainable AI produces clear and understandable results, giving supply chain managers full visibility of the entire process and full control over final decisions.

“It is common to feel simply overwhelmed by an overabundance of data and tools, with many companies struggling to find any tangible business insights,” says Massimiliano Costacurta, Rulex Head of Marketing and Sales for Industry, “Rulex supports companies through every step in the data value chain, so they can quickly transform their raw data into practical business actions in a single tool.”

“Teaming up with OMP, and their in-depth knowledge of supply chain planning, means our customers can develop a solid and superior data value chain, resulting in better decision-making and clear business benefits.”

About OMP

OMP helps companies facing complex planning challenges to excel, grow and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries – spanning consumer goods, life sciences, chemicals, metals, paper, and packaging – benefit from using OMP’s unique Unison Planning™ concept.

About Rulex

Rulex is a leading technology company delivering a no-code, end-to-end data management platform, which orchestrates all the steps in the data value chain (from data collection to pre-processing and advanced analytics), providing businesses with high-quality, trusted, and ready-to-use data.

 

Contact information

OMP	Rulex
Jan Snoeckx OMP Innovation Lead Phone: +32 475 75 04 82 Email: jsnoeckx@omp.com	Claire Thomas Gaggiotti Rulex Head of Sales and Marketing Phone: +39 333 812 8032 Email: claire.thomasgaggiotti@rulex.ai
Paul Delbar OMP Technology Alliance Lead Phone: +32 471 046 662 Email: pdelbar@omp.com

Milan, IT – 16 March 2022

Artificial intelligence serving medical research in Hepatology. A study carried out by Milano-Bicocca University’s Autoimmune Liver Disease Centre at the San Gerardo Hospital in Monza, alongside the Rulex Data Science Team in Genoa, has identified four new Primary Biliary Cholangitis (PBC) subtypes using clinical data from over 12,000 individuals from all over the world. The new algorithm can be added to existing prognostic scores to improve prognostic assessment for patients when they are first diagnosed.

“This is a really important study for us as patients, given the large number of Italian patients included and the potential for innovation offered by artificial intelligence,” explains Davide Salvioni, president of AMAF Onlus, the Italian association of patients with autoimmune liver disease. “A better understanding of these disorders will certainly have a positive impact on doctors’ abilities to manage them more effectively.”

PBC is a liver disease that, although rare, still affects over 10,000 people in Italy, primarily women aged over 40. The past decade has seen gradual improvements in severity stratification for patients with PBC, due in part to the development of new scores and calculators.

In recent years, artificial intelligence and machine learning have been successfully used in the study of common diseases, from infections to cardiovascular disease, breast cancer to colorectal tumors. But until now, experimental evidence for these new technologies and their applications for rare diseases, particularly PBC, was lacking.

The team at Monza’s Autoimmune Liver Disease Centre led by Professor Pietro Invernizzi used Rulex, an innovative data analysis tool. It utilizes a sophisticated artificial intelligence algorithm developed by the Rulex research and development team, coordinated by CEO Marco Muselli, and is based on a theoretical model devised by the CNR Institute for Electronics, Information Technology and Telecommunications in Genoa.

Published in Liver International journal, the study gathered the largest international cohort of PBC patients ever considered, including people from Europe, Japan and North America (DOI: 10.1111/liv.15141). The aim of the research was to draw on the huge amount of data to improve risk stratification for this rare disease. Four subgroups for the disease were identified, in order of increasing clinical severity, based on just three laboratory values: albumin, bilirubin and alkaline phosphatase.

“The Rulex team led by Damiano Verda grouped patients with PBC using a brand-  new approach, creating very simple rules that can be applied by clinicians to classify new patients when they are first diagnosed,” explains Dr. Alessio Gerussi, study leader and researcher at Monza’s Autoimmune Liver Disease Centre.

“But our work doesn’t finish here: in the future, targeted studies will integrate clinical data with data from genetic sequencing, radiology imaging and digital scans of histological slides,” Gerussi goes on. “The objective is to illustrate the disease’s heterogeneity using a much more sophisticated approach, so we can offer patients customized treatment, the ultimate aim of Precision Medicine.”

Read the press release in Italian, Ricerca medica, nuovi risultati in Epatologia con l’intelligenza artificiale.

Learn more about Rulex for medical research.